MedPath
NMPA Approval

Thymopentin for Injection

国药准字H20073975

January 13, 2022

国药准字H20073975

Drug Information

注射用胸腺五肽

注射剂

1mg

化学药品

January 13, 2022

Company Information

Applicant Company

广州市黄埔区东区东博路6号自编一栋自编101房

Manufacturing Company

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用胸腺五肽 - NMPA 批准文号 | MedPath